Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0576 | 0.0453 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0462 | 0.0247 | 0.5448 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0362 | 0.0067 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0462 | 0.0247 | 0.5448 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0576 | 0.0453 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0576 | 0.0453 | 0.0453 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0576 | 0.0453 | 0.1462 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0576 | 0.0453 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0351 | 0.0047 | 0.0151 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Giardia lamblia | GTOR | 0.0576 | 0.0453 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Toxoplasma gondii | FATC domain-containing protein | 0.0462 | 0.0247 | 0.4659 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0576 | 0.0453 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0576 | 0.0453 | 0.1462 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0362 | 0.0067 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.2044 | 0.3096 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0362 | 0.0067 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0576 | 0.0453 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0462 | 0.0247 | 0.5448 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0576 | 0.0453 | 0.0453 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Leishmania major | hypothetical protein, conserved | 0.2155 | 0.3296 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0351 | 0.0047 | 0.1036 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.5876 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0462 | 0.0247 | 0.5448 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0462 | 0.0247 | 0.4659 |
Echinococcus granulosus | serine protein kinase ATM | 0.0462 | 0.0247 | 0.0247 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0576 | 0.0453 | 0.0453 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0576 | 0.0453 | 0.1462 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0576 | 0.0453 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0576 | 0.0453 | 0.1462 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0576 | 0.0453 | 0.0453 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0576 | 0.0453 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0576 | 0.0453 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0576 | 0.0453 | 0.1462 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0462 | 0.0247 | 0.0796 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0462 | 0.0247 | 0.0247 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0576 | 0.0453 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (ADMET) | >= 20.4 uM | Cytotoxicity against human HEL cells assessed as reduction of cell growth | ChEMBL. | 17672445 |
CC50 (ADMET) | >= 20.4 uM | Cytotoxicity against human HEL cells assessed as reduction of cell growth | ChEMBL. | 17672445 |
EC50 (functional) | = 3.8 uM | Antiviral activity against CMV Davis in human HEL cells after 7 days | ChEMBL. | 17672445 |
EC50 (functional) | > 4 uM | Antiviral activity against thymidine kinase-positive VZV OKA in human HEL cells after 7 days | ChEMBL. | 17672445 |
EC50 (functional) | > 4 uM | Antiviral activity against thymidine kinase deficient VZV 07/1 in human HEL cells after 7 days | ChEMBL. | 17672445 |
EC50 (functional) | = 10 uM | Antiviral activity against CMV AD169 in human HEL cells after 7 days | ChEMBL. | 17672445 |
IC50 (functional) | = 8.7 uM | Antiproliferative activity against mouse L1210 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 8.7 uM | Antiproliferative activity against mouse L1210 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 9.6 uM | Antiproliferative activity against human CEM cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 9.6 uM | Antiproliferative activity against human CEM cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 14 uM | Antiproliferative activity against HeLa cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 14 uM | Antiproliferative activity against HeLa cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 18 uM | Antiproliferative activity against SW620 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 18 uM | Antiproliferative activity against SW620 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 19 uM | Antiproliferative activity against MCF7 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 19 uM | Antiproliferative activity against MCF7 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 21 uM | Antiproliferative activity against MiaPaCa2 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 21 uM | Antiproliferative activity against MiaPaCa2 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 23 uM | Antiproliferative activity against H460 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 23 uM | Antiproliferative activity against H460 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
IC50 (functional) | = 37 uM | Antiproliferative activity against human Molt4/C8 cells after 72 hrs by MTT assay | ChEMBL. | 17672445 |
MCC (ADMET) | = 60 uM | Cytotoxicity against human HEL cells assessed as alteration in cell morphology | ChEMBL. | 17672445 |
MCC (ADMET) | = 60 uM | Cytotoxicity against human HEL cells assessed as alteration in cell morphology | ChEMBL. | 17672445 |
MIC (functional) | > 1.6 uM | Antiviral activity against HSV1 KOS in HEL cells assessed as reduction of virus-induced cytopathogenicity | ChEMBL. | 17672445 |
MIC (functional) | > 1.6 uM | Antiviral activity against HSV2 G in HEL cells assessed as reduction of virus-induced cytopathogenicity | ChEMBL. | 17672445 |
MIC (functional) | > 1.6 uM | Antiviral activity against Vaccinia virus in HEL cells assessed as reduction of virus-induced cytopathogenicity | ChEMBL. | 17672445 |
MIC (functional) | > 8 uM | Antiviral activity against VSV in HeLa cells assessed as reduction of virus-induced cytopathogenicity | ChEMBL. | 17672445 |
MIC (functional) | = 8 uM | Antiviral activity against Parainfluenza 3 virus in Vero cells assessed as reduction of virus-induced cytopathogenicity | ChEMBL. | 17672445 |
MIC (functional) | > 8 uM | Antiviral activity against RSV in HeLa cells assessed as reduction of virus-induced cytopathogenicity | ChEMBL. | 17672445 |
MIC (functional) | > 8 uM | Antiviral activity against Reovirus 1 in Vero cells assessed as reduction of virus-induced cytopathogenicity | ChEMBL. | 17672445 |
MIC (functional) | > 8 uM | Antiviral activity against Sindbis virus in Vero cells assessed as reduction of virus-induced cytopathogenicity | ChEMBL. | 17672445 |
MIC (functional) | > 8 uM | Antiviral activity against Coxsackie virus B4 in Vero cells assessed as reduction of virus-induced cytopathogenicity | ChEMBL. | 17672445 |
MIC (functional) | > 8 uM | Antiviral activity against Punta Toro virus in Vero cells assessed as reduction of virus-induced cytopathogenicity | ChEMBL. | 17672445 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 17672445 | |
Mus musculus | ChEMBL23 | 17672445 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.